Role of HLA (Human Leucocyte Antigen) in Human Diseases
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pathology, Diagnostics, and Therapeutics".
Deadline for manuscript submissions: 20 January 2026 | Viewed by 2072
Special Issue Editor
Special Issue Information
Dear Colleagues,
The scope of this Special Issue, titled "Role of HLA (Human Leucocyte Antigen) in Human Diseases", for the International Journal of Molecular Sciences (IJMS) should focus on exploring the molecular mechanisms and biomolecular aspects of HLA in the context of various human diseases. Given that the IJMS is a molecular science journal, this Special Issue should emphasize studies that bridge the clinical relevance of HLA with experimental data, molecular analyses, and in vitro or in vivo models.
Key Areas to Consider
- Molecular Mechanisms of HLA in Disease
- Studies that explore how HLA molecules influence immune responses at the molecular level.
- Investigations into the role of HLA in autoimmune diseases, cancers, and infectious diseases, emphasizing the molecular interactions, signaling pathways, and genetic factors involved.
- Mechanisms of HLA-mediated antigen presentation and how they influence the immune system in various pathological conditions.
- HLA Genotype and Disease Susceptibility
- Biomolecular studies examining the relationship between specific HLA genotypes and susceptibility to diseases (e.g., autoimmune disorders, viral infections, or transplant rejection).
- Molecular characterization of HLA gene variants and their functional implications in disease predisposition.
- HLA in Cancer Immunology
- Molecular studies exploring how HLA plays a role in tumor immune evasion, antigen presentation, and cancer immunotherapy.
- Research into the interaction between HLA molecules and immune checkpoint inhibitors, and their potential in cancer treatment.
- HLA and Infectious Diseases
- Exploration of HLA-mediated immune responses to infections (e.g., HIV, hepatitis, and tuberculosis), with an emphasis on the molecular interactions between HLA molecules and pathogens.
- Studies investigating how HLA influences the immune control of infections at the molecular level.
- Biomolecular Approaches to HLA-based Diagnostics and Therapies
- Development and validation of molecular tools and biomarkers based on HLA for early diagnosis or disease prognosis.
- Novel HLA-based therapeutic strategies, including personalized medicine and targeted therapies.
- Experimental Models and Techniques
- Molecular studies using cell-based or animal models to dissect HLA function and its role in disease mechanisms.
- Use of molecular biology techniques (e.g., CRISPR, RNA sequencing, and proteomics) to study the function and regulation of HLA molecules in disease models.
- HLA and Immune Regulation
- Insights into how HLA molecules regulate immune tolerance, autoimmunity, and inflammatory responses at the molecular level.
- Molecular studies of HLA's involvement in immune checkpoint pathways and its implications for immunotherapy.
Exclusion Criteria
- Pure clinical studies: While clinical data are relevant, studies that do not integrate molecular or experimental approaches are not suitable for this Special Issue.
- Pure model studies without biomolecular analysis: Studies based purely on model organisms or theoretical aspects of HLA without biomolecular experiments should be avoided, unless they explicitly include molecular or experimental data (e.g., gene editing, proteomics, or molecular profiling).
This Special Issue will be dedicated to molecular and biomolecular studies that provide new insights into the functions of HLA in human diseases, focusing on the underlying mechanisms, diagnostic potential, and therapeutic applications. Studies should integrate clinical relevance with molecular experiments to ensure alignment with the scope of the International Journal of Molecular Sciences.
Prof. Dr. Jeane Eliete Laguila Visentainer
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- HLA (human leukocyte antigen)
- molecular immunology
- autoimmune diseases
- HLA genetics
- antigen presentation
- HLA and cancer
- immunotherapy and HLA
- immune responses
- immunity and HLA
- infectious diseases and HLA
- innate and adaptive immunity
- organ transplantation and HLA
- HLA and immune responses
- HLA genotypes and susceptibility
- autoimmunity and HLA
- HLA and infectious diseases
- HLA and personalized therapies
- molecular mechanisms of HLA
- HLA mutations
- experimental models of HLA
- HLA and inflammation
- HLA biomarkers
- HLA and immunosuppression
- immune tolerance and HLA
- immune evasion by HLA
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
